NIAID Announces New Award to Study the Effects of Radiation and Aging on the Human Immune System

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded nearly $9.7 million over five years to the Radiation Effects Research Foundation (RERF), Japan, to study the effects of atomic bomb radiation and aging on the human immune system. For the first time, experts in both the United States and Japan will systematically analyze biological samples from the unique population of elderly Japanese atomic bomb survivors to better understand the health consequences of exposure to ionizing radiation on the natural aging process.

As people grow older, their immune systems also age, leading to a gradual decline in the body’s ability to fight infections, respond to vaccinations and prevent the development of cancer. The aging of the immune system, known as immunosenescence, is a major contributing factor to disease and death among the elderly. Radiation exposure appears to accelerate immunosenescence, although the molecular events that cause immunosenescence are not well understood.

According to the World Health Organization, in 2000 there were approximately 600 million people worldwide 60 years and older; WHO estimates that this number will jump to 1.2 billion by 2025 and 2 billion by 2050.

“Understanding how the immune system ages will help us find better ways to care for this growing population,” says NIAID Director Anthony S. Fauci, M.D.

This study will take advantage of the unique cohort of atomic bomb survivors who were exposed to varying levels of radiation in 1945. Using state-of-the-art technology, investigators will analyze blood samples from survivors to determine how radiation exposure alters the normal age-related decline of the immune system and identify the cellular and molecular changes that occur. They also will determine how the observed immune changes are related to disease and infection. One goal is to understand how exposure to ionizing radiation and aging affect a person’s ability to respond to vaccination.

“We will gain valuable information that will benefit not only the general public but also patients undergoing radiation for cancer treatment and those who could be exposed to radiation from an industrial accident or even a terrorist attack,” says Daniel Rotrosen, M.D., director of NIAI’s Division of Allergy, Immunology, and Transplantation, which oversees this award. “This collaboration complements NIAID’s program to develop medical countermeasures against radiological and nuclear threats.”

Yoichiro Kosunoki, Ph.D., Kei Nakachi, Ph.D., and Tomonori Hayashi, Ph.D., of the Department of Radiobiology/Molecular Epidemiology at RERF, will lead a team of nine experts in Japan and in the United States:

Yoko Hirabayashi, M.D., National Institute of Health Sciences, Tokyo, Japan

  • Atsushi Iwama, M.D., Chiba University, Japan
  • Shigeo Koyasu, Ph.D., Keio University, Tokyo, Japan
  • Nancy Manley, Ph.D., University of Georgia, Athens
  • Janko Nikolich-Zugich, M.D., Ph.D., University of Arizona, Tucson
  • Gregory Sempowski, Ph.D., Duke University, Durham, N.C.
  • Marcel van den Brink, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center, New York City
  • Nan-ping Weng, M.D., Ph.D., National Institute on Aging, National Institutes of Health, Baltimore
  • Koji Yasutomo, M.D., Ph.D., University of Tokushima, Japan

RERF, formerly known as the Atomic Bomb Casualty Commission, is a cooperative Japan-U.S. scientific organization that has been in existence for 62 years and is based in Hiroshima and Nagasaki, Japan. The foundation performs research to evaluate and document the long-term health effects of acute radiation exposure on survivors of the atomic bomb. For more information about RERF, visit www.rerf.or.jp.

The NIA leads the federal government effort conducting and supporting research on the biomedical, social and behavioral issues of older people. For more information on aging-related research and the NIA, go to www.nia.nih.gov.

NIAID conducts and supports research — at NIH, throughout the United States, and worldwide — to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at www.niaid.nih.gov.

The National Institutes of Health (NIH) — The Nation’s Medical Research Agency — includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

Related posts:

  1. Medicare – NIA Funds Centers to Study Demography of Aging The National Institute on Aging (NIA), part of the National Institutes of Health, today announced that it has committed more than $36.7 million over the next five years to support and expand its Centers on the Demography and Economics of Aging. The Centers form a network of universities and organizations leading innovative studies on the characteristics of the aging population. The awards, which include some support from the American Recovery and Reinvestment Act, renewed support for 11 Centers and established three new ones....
  2. Effort to define markers of human immune responses to infection and vaccination A new nationwide research initiative has been launched to define changes in the human immune system, using human and not animal studies, in response to infection or to vaccination. Six U. S.-based Human Immune Phenotyping Centers will receive a total of $100 million over five years to conduct this research....
  3. Summit to focus on management of radiation dose in computerized tomography Members of the media are invited to attend a National Institutes of Health conference focused on transforming computed tomography (CT) technology and its use to achieve minimal public health risks from radiation exposure. A specific goal of this conference is to identify the technological steps and associated research required to reduce the radiation dose from […]...
  4. Medicare, Study of MicroRNA, Helps NIH Scientists, Unlock Secrets of Immune Cells With the rapid and continuous advances in biotechnology, scientists are better able to see inside the nucleus of a cell to unlock the secrets of its genetic material. However, what happens outside of the nucleus has, in many ways, remained a mystery. Now, researchers with the National Institutes of Health are closer to understanding how […]...
  5. MedicareCard.com, Experimental Immune, Boosting Drug Worsens TB in Mice An experimental drug that boosts production of the immune system protein interferon worsens tuberculosis (TB) in mice, according to scientists from the National Institutes of Health. The drug acts indirectly by drawing certain immune cells, in which Mycobacterium tuberculosis (M.tb) bacteria thrive, to the lungs. The findings may have potential implications for the care of people infected with TB, the authors note. The research is reported in the May 3 issue of Journal of Clinical Investigation, now available online....
  6. Aging & Disability Resource Centers (ADRCs) Aging & Disability Resource Centers (ADRCs)...
  7. Study identifies gene that suppresses cell’s immune activation A new study of prostate tumors has shown that a gene, FOXO3, suppresses activation of cells related to immunity and thus leads to a reduced immune response against a growing cancer. One of the main problems in treating cancer by vaccine or immunotherapy is that tumors often evade the body’s immune response — and one […]...
  8. Medicare Help, Immune Cell’s Role, Lupus Nephritis Demonstrated, Paves Way for Safety Testing, of Potential New Use for Asthma Drug National Institutes of Health scientists have discovered that the activation of immune cells called basophils causes kidney damage in a mouse model of lupus nephritis. These findings and the team’s associated research in humans may lead to new treatments for this serious disease, a severe form of systemic lupus erythematosus (SLE) that affects the kidneys […]...
  9. Getting Older – Mental Exercise May Aid Aging Minds Getting Older - Mental Exercise May Aid Aging Minds...
  10. NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. This finding by scientists co-funded by the National Institute […]...
  11. Study Indicates: Disability Among Older Americans Declines Study Indicates: Disability Among Older Americans Declines...
  12. Medicare Information Psychopathic Traits Linked to Brain Reward System People who scored high on a test that measures impulsive and antisocial traits had exaggerated brain responses to certain “rewards,” like winning money or taking stimulant drugs. The new study provides evidence that a dysfunctional brain reward system may underlie vulnerability to a personality disorder known as psychopathy. ...
  13. MedicarCard.com, NIH, Human Microbiome Project, Researchers Publish First Genomic, Collection of Human Microbes The Human Microbiome Project (HMP) today published an analysis of 178 genomes from microbes that live in or on the human body. The researchers discovered novel genes and proteins that serve functions in human health and disease, adding a new level of understanding to what is known about the complexity and diversity of these organisms....
  14. NIH Announces New Awards in Program to Expand Interdisciplinary Research Careers in Women’s Health Almost $6 million has been awarded to investigators and programs to help researchers in the early stages of careers in women’s health research. The funding is from the National Institutes of Health’s Office of Research on Women’s Health (ORWH) and other co-sponsors. The money will go to 12 new and continuing Building Interdisciplinary Research Careers […]...
  15. Medicare Medical Care, Rapid Development of Drug-Resistant, 2009 H1N1 Influenza Reported in Two Cases Two people with compromised immune systems who became ill with 2009 H1N1 influenza developed drug-resistant strains of virus after less than two weeks on therapy, report doctors from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Doctors who treat prolonged influenza infection should be aware that even a short course of antiviral treatment may lead to drug-resistant virus, say the authors, and clinicians should consider this possibility as they develop initial treatment strategies for their patients who have impaired immune function....